Prostate Cancer
TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)
- Details
ClinicalTrials.gov ID:
NCT02975934
Diagnosis Type:
NA
USOR Number:
- Address
603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206